Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions-Reference-Cited by-同舟云学术

Regulating pediatric off-label uses of medicines in the EU and USA: challenges and potential solutions

Published:2021-09-08 Issue: Volume: Page:
ISSN:2210-7703
Container-title:International Journal of Clinical Pharmacy
language:en
Short-container-title:Int J Clin Pharm

Author:

Guidi Benedetta^ORCID,Parziale Andrea,Nocco Luca,Maiese Aniello,La Russa Raffaele,Di Paolo Marco,Turillazzi Emanuela

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy

Link

https://link.springer.com/content/pdf/10.1007/s11096-021-01303-5.pdf

Reference29 articles.

1. Lenk C. Off-label drug use in paediatrics: a world-wide problem. Curr Drug Targets. 2012;13(7):878–84.

2. Russo C, Stout L, House T, Santana VM. Barriers and facilitators of clinical trial enrollment in a network of community-based pediatric oncology clinics. Pediatr Blood Cancer. 2020;67(4):e28023.

3. Schiavone S, Neri M, Pomara C, Riezzo I, Trabace L, Turillazzi E. Personalized medicine in the paediatric population: the balance between pharmacogenetic progress and bioethics. Curr Pharm Biotechnol. 2017;18(3):253–62.

4. European Commission. Study on off-label use of medicinal products in the European Union.

5. Bruxelles. 2017. Available online: https://ec.europa.eu/health/sites/health/files/files/documents/2017_02_28_final_study_report_on_of-label_use_.pdf.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Next-generation pediatric care: nanotechnology-based and AI-driven solutions for cardiovascular, respiratory, and gastrointestinal disorders;World Journal of Pediatrics;2024-08-28

2. Potential drug–drug interactions analysis in Polish pediatric pneumonology units, including cystic fibrosis patients;The Journal of Clinical Pharmacology;2024-06-03

3. Barriers and facilitators to guideline for the management of pediatric off-label use of drugs in China: a qualitative descriptive study;BMC Health Services Research;2024-04-05

4. Application of 3D printing technology for the development of dose adjustable geriatric and pediatric formulation of celecoxib;International Journal of Pharmaceutics;2024-04

5. Should secondary pharmacogenomic variants be actively screened and reported when diagnostic genome-wide sequencing is performed in a child?;Genetics in Medicine;2024-02